Seqens Seqens

X

Find Frovatriptan Succinate Hydrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

DSSTox_CID_28982
Also known as: 158930-17-7, Frovatriptan succinate hydrate, Frovatriptan succinate monohydrate, Frovatriptan succinate [usan], Frovelan, Migard
Molecular Formula
C18H25N3O6
Molecular Weight
379.4  g/mol
InChI Key
CUETXFMONOSVJA-KLQYNRQASA-N
FDA UNII
D28J6W18HY

Frovatriptan Succinate is the succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity. Frovatriptan succinate binds selectively and with high affinity to 5-HT 1B and presynaptic 5-HT 1D receptors in the extracerebral and intracranial arteries. This leads to an inhibition of serotonin activity and results in vasoconstriction of the painfully dilated blood vessels during migraine attack. Frovatriptan succinate is indicated for the acute treatment of migraine. (NCI05)
1 2D Structure

DSSTox_CID_28982

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
2.1.2 InChI
InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1
2.1.3 InChI Key
CUETXFMONOSVJA-KLQYNRQASA-N
2.1.4 Canonical SMILES
CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
2.1.5 Isomeric SMILES
CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
2.2 Other Identifiers
2.2.1 UNII
D28J6W18HY
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (+)-(r)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide Succinate (1:1), Monohydrate

2. 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole

3. Allegro

4. Frova

5. Frovatriptan

6. Frovelan

7. Sb 209509

8. Vml-251

9. Vml251

2.3.2 Depositor-Supplied Synonyms

1. 158930-17-7

2. Frovatriptan Succinate Hydrate

3. Frovatriptan Succinate Monohydrate

4. Frovatriptan Succinate [usan]

5. Frovelan

6. Migard

7. Vml 251

8. Sb 209509-ax

9. D28j6w18hy

10. Sb 209509 Ax

11. Nsc-760422

12. Ncgc00183880-01

13. Butanedioic Acid;(6r)-6-(methylamino)-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide;hydrate

14. (+)-(r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide Butanedioate (1:1), Monohydrate

15. (+)-(r)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide Succinate (1:1), Monohydrate

16. Butanedioic Acid, Compd. With (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide (1:1), Monohydrate

17. Butanedioic Acid, Compd. With (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide, Hydrate (1:1:1)

18. Frovatriptan Succinate (usan)

19. Frovatriptan (succinate Hydrate)

20. (r)-3-(methylamino)-2,3,4,9-tetrahydro-1h-carbazole-6-carboxamide Succinate Hydrate

21. Butanedioic Acid,(6r)-6-methylamino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide;hydrate

22. Unii-d28j6w18hy

23. Frova (tn)

24. Dsstox_cid_28982

25. Dsstox_rid_83247

26. Dsstox_gsid_49056

27. Schembl2321442

28. Chembl2138684

29. Dtxsid2049056

30. Hy-b1658a

31. Tox21_113606

32. Akos030241886

33. Frovatriptan Succinate [mart.]

34. Frovatriptan Succinate [usp-rs]

35. Nsc 760422

36. 1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (r)-, Butanedioate (1:1), Monohydrate

37. Frovatriptan Succinate [orange Book]

38. Cas-158930-17-7

39. Cs-0021309

40. D04264

41. Frovatriptan Succinate Monohydrate [mi]

42. Frovatriptan Succinate Monohydrate [who-dd]

43. Frovatriptan Succinate Monohydrate, >=97% (hplc)

44. J-009548

45. Q27276007

46. Frovatriptan Succinate, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 379.4 g/mol
Molecular Formula C18H25N3O6
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass379.17433553 g/mol
Monoisotopic Mass379.17433553 g/mol
Topological Polar Surface Area147 Ų
Heavy Atom Count27
Formal Charge0
Complexity426
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Serotonin Receptor Agonists

Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY